Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single-dose dose-escalation study of TMS-008 in healthy adult male subjects
jRCT2031240084Phase 1Completed
- Sponsor
- TMS Co., Ltd.
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of TMS-008 in acute kidney failure (AKF) (2 arms), sponsored by TMS Co., Ltd. Primary endpoints: Safety, Pharmacokinetics and 1 more. Started Jun 2024; status: completed.
02
Drugs
TMS-008
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on jRCT2031240084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240084.